Financials
Friday, December 23, 2016
BRIEF-Highbridge Capital Management reports 5.3 pct passive stake in Protalix Biotherapeutics
* Highbridge Capital Management Reports 5.3 Pct passive
stake in Protalix Biotherapeutics Inc as of Dec. 13
Source text: (http://bit.ly/2ioIPpE)
Further company coverage:
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment